The ninth Capital Cell Investment Forum will be held on 7 November in Barcelona, presenting the latest rounds of investment active in biotechnology and health in Spain. Noteworthy among these rounds: Made of Genes (personalised medicine in genomics) and Qmenta (artificial intelligence applied to medical imaging), which are CataloniaBio & HealthTech members.

Interested investors will have the opportunity to hear the start-ups' pitches and hold private meetings with their executive teams.

Since 2015, Capital Cell has closed 34 rounds of funding for a total of €21 million, with co-investors that include Alta Life Sciences, Genesis Biomed, Inveready, Ship2B and WA4Steam.

Language: Spanish

Registration fees: free of charge

More information